Genentech National Cooperative Growth Study Surveillance Program for Nutropin AQ, Nutropin, and Protropin

This study is currently recruiting participants.

Verified by Emory University, October 2005

Sponsored by:	Emory University
Information provided by:	Emory University
ClinicalTrials.gov Identifier:	NCT00231361

Purpose

This is an observational research study (called a registry) for growth failure. The purpose is to collect information on those who use Genentech growth hormone.

Condition	Intervention
Growth Disorders	Drug: Growth hormone

MedlinePlus related topics: Growth Disorders

Drug Information available for: Somatotropin Somatropin

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Cross-Sectional, Defined Population, Retrospective Study
Official Title:	Genentech National Cooperative Growth Study (NCGS) Post Marketing Surveillance Program for Nutropin AQ (Somatropin [rDNA Origin] Injection), Nutropin (Somatropin [rDNA Origin] for Injection) and Protropin (Somatrem for Injection)

Further study details as provided by Emory University:

Estimated Enrollment:	25
Study Start Date:	August 2005

Detailed Description:

This is an observational research study (called a registry) for growth failure. The purpose is to collect information on those who use Genentech growth hormone.

Eligibility

Ages Eligible for Study:	18 Years to 22 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Growth failure

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00231361

Contacts

Contact: Melissa Hamilton, BS

404-785-1717

Melissa.Hamilton@choa.org

Locations

United States, Georgia
Children's Healthcare of Atlanta	Recruiting
Atlanta, Georgia, United States, 30322
Contact: JoAnn Sadowski, BS 404-785-3531 Joann.Sadowski@choa.org
Principal Investigator: Lillian R. Meacham, MD

Sponsors and Collaborators

Emory University

Investigators

Principal Investigator:

Lillian R. Meacham, MD

Children's Healthcare of Atlanta

More Information

Study ID Numbers:	334-2005
Study First Received:	October 3, 2005
Last Updated:	December 13, 2006
ClinicalTrials.gov Identifier:	NCT00231361
Health Authority:	United States: Institutional Review Board

Keywords provided by Emory University:

Growth failure
Pediatric population

Study placed in the following topic categories:

Growth Disorders

Additional relevant MeSH terms:

Pathologic Processes

ClinicalTrials.gov processed this record on January 14, 2009